Overview Executive Committee Supervisory Board Locations
Overview Satraplatin Kinase Inhibitors
Stock

Major Shareholdings

Key Figures Financial Reports SEC Filings Corporate Governance Analyst Coverage Shareholder´s Meeting Webcasts Information Request
Press Releases Contact Information
Working for GPC Biotech Germany USA

More Info

Print preview

Print

Investor Relations


Major Shareholdings

Comments on Publication according to Sec. 26 para. 1 WpHG as of September 17, 2008

For clarification purposes GPC Biotech announces in connection with the notification according to Sec. 26 para. 1 WpHG (pls. see below) dated September 17, 2008, that its major shareholder still remains "Golf Club St. Leon-Rot Betriebsgesellschaft mbH & Co. KG" and "Verwaltungsgesellschaft of Golf Club St. Leon-Rot mbH" respectively, holding a stake of 17.10% as announced on January 2, 2008. As also announced on January 2, 2008, 7,76% of this 17,10% voting rights still remain attributable to  "dievini Hopp BioTech holding GmbH & Co. KG" (formerly known as "dievini Hopp BioTech GmbH & Co. KG). The changes as stated in the notification dated September 17, 2008 are a result of a smaller internal reorganization within the companies around "dievini Hopp BioTech holding GmbH & Co. KG".

 

According to "dievini Hopp BioTech holding GmbH & Co. KG" the transfer of shares was due to internal restructuring reasons already planned some time ago; the share of "dievini Hopp BioTech holding GmbH & Co. KG" in GPC Biotech AG hasn't changed according to "dievini Hopp BioTech holding GmbH & Co. KG".

 

 
Publication according to Sec. 26 para. 1 WpHG as of September 17, 2008

In a letter dated September 12, 2008 Prof. Dr. Christof Hettich and Dr. Friedrich von Bohlen und Halbach, Germany, have informed us according to Sec. 21 para. 1 WpHG in the name of dievini Verwaltungs GmbH, Heidelberg, Germany, registered at commercial register at AG Mannheim (HRB 701940) and represented by them, that the percentage of voting shares dievini Verwaltungs GmbH holds in GPC Biotech AG (WKN 585 150, ISIN DE0005851505) fell below the 5% and 3% tresholds on September 8, 2008 and now is 0% (which equals voting rights out of 0 shares).

 

In a letter dated September 12, 2008 Prof. Dr. Christof Hettich, Germany, has informed us according to Sec. §21 para. 1 WpHG, that the percentage of voting shares he owns in GPC Biotech AG (WKN 585 150, ISIN DE0005851505) fell below the 5% and 3% thresholds at September 8, 2008 and now is 0 % (which equals voting rights out of 0 shares).

 

In a letter dated September 12, 2008 Dr. Friedrich von Bohlen und Halbach, Germany, informed us according to Sec. 21 para. 1 WpHG, that the percentage of voting shares he owns in GPC Biotech AG (WKN 585 150, ISIN DE0005851505) fell below the 5% and 3% thresholds at September 8, 2008 and now is 0 % (which equals voting rights out of 0 shares).

 

Martinsried/Planegg, September 17, 2008

 

GPC Biotech AG

 

The Management

Investor Relations | Major Shareholdings